Literature DB >> 20423708

Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.

Hongwen Zhu1, Jennifer J O'Brien, James P O'Callaghan, Diane B Miller, Qiang Zhang, Minal Rana, Tiffany Tsui, Youyi Peng, John Tomesch, Joseph P Hendrick, Lawrence P Wennogle, Gretchen L Snyder.   

Abstract

Organophosphorus (OP) compounds cause toxic symptoms, including convulsions, coma, and death, as the result of irreversible inhibition of acetylcholinesterase (AChE). The development of effective treatments to block these effects and attenuate long-term cognitive and motor disabilities that result from OP intoxication is hampered by a limited understanding of the CNS pathways responsible for these actions. We employed a candidate method (called CNSProfile) to identify changes in the phosphorylation state of key neuronal phosphoproteins evoked by the OP compound, diisopropyl fluorophosphate (DFP). Focused microwave fixation was used to preserve the phosphorylation state of phosphoproteins in brains of DFP-treated mice; hippocampus and striatum were analyzed by immunoblotting with a panel of phospho-specific antibodies. DFP exposure elicited comparable effects on phosphorylation of brain phosphoproteins in both C57BL/6 and FVB mice. DFP treatment significantly altered phosphorylation at regulatory residues on glutamate receptors, including Serine897 (S897) of the NR1 NMDA receptor. NR1 phosphorylation was bi-directionally regulated after DFP in striatum versus hippocampus. NR1 phosphorylation was reduced in striatum, but elevated in hippocampus, compared with controls. DARPP-32 phosphorylation in striatum was selectively increased at the Cdk5 kinase substrate, Threonine75 (T75). Phencynonate hydrochloride, a muscarinic cholinergic antagonist, prevented seizure-like behaviors and the observed changes in phosphorylation induced by DFP. The data reveal region-specific effects of nerve agent exposure on intracellular signaling pathways that correlate with seizure-like behavior and which are reversed by the muscarinic receptor blockade. This approach identifies specific targets for nerve agents, including substrates for Cdk5 kinase, which may be the basis for new anti-convulsant therapies. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423708      PMCID: PMC2885509          DOI: 10.1016/j.brainres.2010.04.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  Coordinated PKA and PKC phosphorylation suppresses RXR-mediated ER retention and regulates the surface delivery of NMDA receptors.

Authors:  Derek B Scott; Thomas A Blanpied; Michael D Ehlers
Journal:  Neuropharmacology       Date:  2003-11       Impact factor: 5.250

Review 2.  Nicotinic acetylcholine receptors: from structure to brain function.

Authors:  R C Hogg; M Raggenbass; D Bertrand
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-03-20       Impact factor: 5.545

Review 3.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

4.  Eighteen cases exposed to sarin in Matsumoto, Japan.

Authors:  J Suzuki; T Kohno; M Tsukagosi; T Furuhata; K Yamazaki
Journal:  Intern Med       Date:  1997-07       Impact factor: 1.271

5.  Bidirectional changes in synapsin I phosphorylation at MAP kinase-dependent sites by acute neuronal excitation in vivo.

Authors:  Yoko Yamagata; Jasmina N Jovanovic; Andrew J Czernik; Paul Greengard; Kunihiko Obata
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

6.  Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals.

Authors:  J N Jovanovic; T S Sihra; A C Nairn; H C Hemmings; P Greengard; A J Czernik
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

7.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.

Authors:  Frank P Bymaster; Petra A Carter; Masahisa Yamada; Jesus Gomeza; Jürgen Wess; Susan E Hamilton; Neil M Nathanson; David L McKinzie; Christian C Felder
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

9.  Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5.

Authors:  S D Norrholm; J A Bibb; E J Nestler; C C Ouimet; J R Taylor; P Greengard
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Control of nerve agent-induced seizures is critical for neuroprotection and survival.

Authors:  Tsung-Ming Shih; Steven M Duniho; John H McDonough
Journal:  Toxicol Appl Pharmacol       Date:  2003-04-15       Impact factor: 4.219

View more
  8 in total

Review 1.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

2.  Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum.

Authors:  Melissa I Torres-Altoro; Brian N Mathur; Justin M Drerup; Rachel Thomas; David M Lovinger; James P O'Callaghan; James A Bibb
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

3.  Characterization of status epilepticus induced by two organophosphates in rats.

Authors:  Marko S Todorovic; Morgan L Cowan; Corrinee A Balint; Chengsan Sun; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2012-05-09       Impact factor: 3.045

4.  Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman.

Authors:  Asheebo Rojas; Hilary S McCarren; Jennifer Wang; Wenyi Wang; JuanMartin Abreu-Melon; Sarah Wang; John H McDonough; Raymond Dingledine
Journal:  Neurotoxicology       Date:  2020-12-19       Impact factor: 4.294

5.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

6.  Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.

Authors:  Gretchen L Snyder; Kimberly E Vanover; Hongwen Zhu; Diane B Miller; James P O'Callaghan; John Tomesch; Peng Li; Qiang Zhang; Vaishnav Krishnan; Joseph P Hendrick; Eric J Nestler; Robert E Davis; Lawrence P Wennogle; Sharon Mates
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

7.  Corticosterone primes the neuroinflammatory response to Gulf War Illness-relevant organophosphates independently of acetylcholinesterase inhibition.

Authors:  Alicia R Locker; Lindsay T Michalovicz; Kimberly A Kelly; Julie V Miller; Diane B Miller; James P O'Callaghan
Journal:  J Neurochem       Date:  2017-06-14       Impact factor: 5.372

8.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.